| NCT04211636 | Autoimmunity And Immune Deficiency After Spinal Cord Injury: Association With Rehabilitation Outcomes | Charite University, Berlin, Germany | | - Age 18 - 75 yrs
- Level C3-L2
AIS A, B, C, D- ≤ 3 weeks
| Recruiting soon | 81 | | | General health | | | 01 October 2023 | 26 December 2019 | 2 | |
| NCT04217525 | Duke Spine Outcome Study (DSOS) | Duke University | | - Age 18 - 85 yrs
- Level C1-S5
AIS A, B, C, D- ≥ 0 hours
| Recruiting | 900 | | | General health | | | 03 December 2019 | 03 January 2020 | 1 | |
| NCT04475224 | Phase 3 Study of KP-100IT in Subjects With Acute Spinal Cord Injury | Kringle Pharma, Inc. | | - Age 18 - 89 yrs
- Level C4-C8
AIS A- ≤ 78 hours
| | 25 | PHASE3 | Drug | General health | | | 13 July 2020 | 17 July 2020 | 5 | |
| NCT04528550 | Autologous Bone Marrow-derived Mononuclear Cells for Acute Spinal Cord Injury | Shanghai Changzheng Hospital | | - Age 18 - 60 yrs
- Level C1-S5
AIS A, B, C, D- ≤ 2 weeks
| | 45 | PHASE2 | Biological/cell based | General health | | | 01 October 2020 | 27 August 2020 | 1 | |
| NCT04550117 | Intraspinal Pressure Monitoring for Acute Traumatic Spinal Cord Injury: A Validation Study | University of Manitoba | | - Age 18 - 70 yrs
- Level C1-S5
AIS A, B, C- ≤ 48 hours
| | 20 | NA | Surgery | General health | | | 23 June 2020 | 16 September 2020 | 1 | |
| NCT01701388 | EKSO Trial: Powered Exoskeleton for Ambulation in Subjects With Spinal Cord Injury (SCI) | Shirley Ryan AbilityLab | | - Age 18 - 65 yrs
- Level C7-S1
AIS A, B, C, D- ≥ 0 hours
| Active | 40 | NA | Rehabilitation | Standing/walking/mobility | | | 01 May 2012 | 05 October 2012 | 1 | |
